Reblozyl

NDC 59572-775 · Celgene Corporation

Generic nameLuspatercept

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteSUBCUTANEOUS

Active ingredient(s)LUSPATERCEPT

Strength75 mg/1

Pharmacologic classErythroid Maturation Agent [EPC], Increased Erythroid Cell Production [PE]

Marketing categoryBLA

Packages

59572-775-01 — 1 VIAL, GLASS in 1 CARTON (59572-775-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS

J0896 — Injection, luspatercept-aamt, 0.25 mg Medicare Part B payment limit (ASP + 6%): $43.51

FDA lists these products with the same active ingredient.

59572-711 — Luspatercept

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.